Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

More money for DM programmes despite doubts

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    More money for DM programmes despite doubts. Pharmacoecon. Outcomes News 96, 11 (1997). https://doi.org/10.1007/BF03271266

    Download citation


    • Disease Management
    • Drug Company
    • Disease Management Programme
    • Health Maintenance Organisation
    • Management Institute